Review
Open access
Jul 2026
CDK4/6 Inhibitors in Breast Cancer: Clinical Applications, Translational Insights, and Future Directions
This review examines the clinical development of palbociclib, ribociclib, and abemaciclib across both early-stage and metastatic settings, revealing clinically meaningful differences in efficacy that challenge the notion of a uniform class effect.
Mengying Guan, Hua Hao
· Cancers · 0 citations